Utang jangka cendhak marang ekuitas American Oncology Network (AONC)

Logo grafis American Oncology Network (AONC)

American Oncology Network (AONC) is actively expanding by consolidating private medical centers and implementing advanced digital data management systems. The recruitment of specialists is based on an ethical approach and the preservation of physician independence. This daily price chart complements data on profits from clinic administration and drug sales, where the indicator stands at 0.00.

AONC - Rasio utang jangka cendhak marang ekuitas American Oncology Network ing rentang 21.02.2024 - 04.08.2024
Produk mawa merek aoncology.com

This indicator assesses short-term debt load relative to equity, determining the extent of the company's reliance on short-term borrowings to maintain liquidity. By analyzing the short-term debt-to-equity ratio, an investor can discern the balance between financial risks and expansion rates, which is critical for American Oncology Network (AONC): high margins driven by regional dominance and drug procurement optimization allow the company to efficiently service current liabilities without compromising growth.

Pesaing American Oncology Network

Utang jangka cendhak marang modal ONC|Utang jangka cendhak marang modal Halozyme Corp (HALO)|Utang jangka cendhak marang ekuitas Revolution Medicines RVMD|AAPG: Rasio utang jangka cendhak marang modal|CG Oncology - Utang jangka cendhak marang modal|UroGen Pharma Ltd (URGN) - Rasio utang jangka cendhak marang ekuitas|BCAX: Utang jangka cendhak marang modal|Kewajiban jangka cendhak marang modal Personalis Genomics (PSNL)|Utang jangka cendhak marang ekuitas Erasca, Inc.|DCTH: Rasio tanggungan utang jangka cendhak marang modal|Rasio utang jangka cendhak marang ekuitas YMAB (Y-mAbs Therapeutics, Inc.)|AURA (Aura Biosciences Inc) - Rasio tanggungan utang jangka cendhak marang modal|Utang jangka cendhak marang modal CADL (Candel Therapeutics, Inc.)|ARAY - Rasio utang jangka cendhak marang ekuitas|SLS: Rasio utang jangka cendhak marang ekuitas|ACTU - Utang jangka cendhak marang modal|Citius Oncology (CTOR) - Utang jangka cendhak marang ekuitas|TuHURA Biosciences - Rasio tanggungan utang jangka cendhak marang modal|TARA (Protara) - Utang jangka cendhak marang modal|Kewajiban jangka cendhak marang modal Fate Pharma FATE|Utang jangka cendhak marang modal WHWK|Utang jangka cendhak marang modal tscan.com (TCRX)|Utang jangka cendhak marang ekuitas Champions Oncology, Inc. CSBR|XBIT - Rasio utang jangka cendhak marang ekuitas|CEL-SCI Corp - Utang jangka cendhak marang modal|Kewajiban jangka cendhak marang modal OS Therapies, Inc.|Radiopharm Theranostics (RADX) - Utang jangka cendhak marang ekuitas|Artiva Biotherapeutics - Rasio tanggungan utang jangka cendhak marang modal|ANL (Adlai Nortye Ltd) - Utang jangka cendhak marang modal|Veru Inc (VERU) - Koefisien utang jangka cendhak marang modal|Utang jangka cendhak marang modal TPST|Rasio utang jangka cendhak marang ekuitas xiliotx.com XLO|Utang jangka cendhak marang modal RENB (Renovaro)|Utang jangka cendhak marang modal Mural Oncology PLC MURA|KAPA - Utang jangka cendhak marang ekuitas|OKUR (OnKure Therapeutics Inc) - Rasio utang jangka cendhak marang modal|GDTC (w2.cytomed.sg) - Rasio utang jangka cendhak marang ekuitas|Curis - Rasio tanggungan utang jangka cendhak marang modal|Utang jangka cendhak marang ekuitas Apollomics Inc.|Kewajiban jangka cendhak marang modal tharimmune.com THAR|Utang jangka cendhak marang ekuitas Advanced Biomed Inc (ADVB)|Genprex Inc. - Rasio utang jangka cendhak marang modal|Utang jangka cendhak marang modal CLDI (Calidi Biotherapeutics, Inc.)|SBFM - Rasio utang jangka cendhak marang ekuitas|XBIO - Utang jangka cendhak marang ekuitas|Kewajiban jangka cendhak marang modal salariuspharma.com|Purple Biotech Ltd. (PPBT) - Utang jangka cendhak marang ekuitas|BGNE (BeiGene Ltd.) - Utang jangka cendhak marang ekuitas|Utang jangka cendhak marang ekuitas Checkpoint Therapeutics, Inc|Kewajiban jangka cendhak marang modal Elevation Oncology Inc. ELEV|Utang jangka cendhak marang modal ICAD|ikenaoncology.com (IKNA) - Tanggungan utang jangka cendhak marang ekuitas|Notable Labs - Rasio utang jangka cendhak marang ekuitas|Viracta Therapeutics Inc. (VIRX) - Kewajiban jangka cendhak marang modal|MOR: Rasio utang jangka cendhak marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal NAYA (NAYA Biosciences Corp)|Ascentage Pharma Group (AAPGV) - Utang jangka cendhak marang ekuitas